Anita Schaffer | Authors


Expert Reviews Sequencing Strategies for Explosion of New CLL Treatment Options

November 04, 2020

While the treatment landscape for chronic lymphocytic leukemia has expanded with an explosion of new therapeutic options, physicians are plagued with questions about sequencing therapies for those who progress following therapy in the first-line setting, and little data exists to guide optimal therapy selection, according to Anthony Mato, MD.

Broad-Panel NGS Benefits Metastatic NSCLC

January 11, 2019

Increasing clinical relevance of less common gene signatures and alterations is leading to a benefit from broad-panel next-generation sequencing testing for patients with metastatic non–small cell lung cancer, according to an expert at Memorial Sloan Kettering Cancer Center.